Ferroptosis in Cognitive Impairment Associated with Diabetes and Alzheimer's Disease: Mechanistic Insights and New Therapeutic Opportunities

被引:2
作者
Ma, Mei [1 ]
Jing, Guangchan [1 ]
Tian, Yue [1 ]
Yin, Ruiying [1 ]
Zhang, Mengren [1 ]
机构
[1] Peking Union Med Coll & Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Tradit Chinese Med, Beijing 100730, Peoples R China
关键词
Ferroptosis; Cognitive impairment; Alzheimer's disease; Diabetes; Natural products; BRAIN IRON DEPOSITION; INSULIN-RESISTANCE; PC12; CELLS; IN-VIVO; ACCUMULATION; PEROXIDATION; DYSFUNCTION; EXPRESSION; APOPTOSIS; PROTECTS;
D O I
10.1007/s12035-024-04417-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Cognitive impairment associated with diabetes and Alzheimer's disease has become a major health issue affecting older individuals, with morbidity rates growing acutely each year. Ferroptosis is a novel form of cell death that is triggered by iron-dependent lipid peroxidation. A growing body of evidence suggests a strong correlation between the progression of cognitive impairment and diabetes, Alzheimer's disease, and ferroptosis. The pharmacological modulation of ferroptosis could be a promising therapeutic intervention for cognitive impairment associated with diabetes and Alzheimer's disease. In this review, we summarize evidence on ferroptosis in the context of cognitive impairment associated with diabetes and Alzheimer's disease and provide detailed insights into the function and potential action pathways of ferroptosis. Furthermore, we discuss the therapeutic importance of natural ferroptosis products in improving the cognitive impairment associated with diabetes and Alzheimer's disease and provide new insights for clinical treatment.
引用
收藏
页码:2435 / 2449
页数:15
相关论文
共 50 条
  • [31] Therapeutic Insights on Ferroptosis in Parkinson's disease
    Thapa, Komal
    Khan, Heena
    Kanojia, Neha
    Singh, Thakur Gurjeet
    Kaur, Amarjot
    Kaur, Gagandeep
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2022, 930
  • [32] Neuronal death in Alzheimer's disease and therapeutic opportunities
    Donev, Rossen
    Kolev, Martin
    Millet, Bruno
    Thome, Johannes
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2009, 13 (11-12) : 4329 - 4348
  • [33] Alkaloids as drug leads in Alzheimer ' s treatment: Mechanistic and therapeutic insights
    Islam, Md. Rezaul
    Akash, Shopnil
    Islam, Mohammed Murshedul
    Sarkar, Nadia
    Kumer, Ajoy
    Chakraborty, Sandip
    Dhama, Kuldeep
    Al-Shaeri, Majed Ahmed
    Anwar, Yasir
    Wilairatana, Polrat
    Rauf, Abdur
    Halawani, Ibrahim F.
    Alzahrani, Fuad M.
    Khan, Haroon
    BRAIN RESEARCH, 2024, 1834
  • [34] Mechanistic and Etiological Similarities in Diabetes Mellitus and Alzheimer's Disease: Antidiabetic Drugs as Optimistic Therapeutics in Alzheimer's Disease
    Das, Subham
    Ramachandran, Anu Kunnath
    Halder, Debojyoti
    Akbar, Saleem
    Ahmed, Bahar
    Joseph, Alex
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2023, 22 (07) : 973 - 993
  • [35] The role of endocannabinoid pathway in the neuropathology of Alzheimer's disease: Can the inhibitors of MAGL and FAAH prove to be potential therapeutic targets against the cognitive impairment associated with Alzheimer's disease?
    Bajaj, Shivanshu
    Jain, Shreshta
    Vyas, Preeti
    Bawa, Sandhya
    Vohora, Divya
    BRAIN RESEARCH BULLETIN, 2021, 174 : 305 - 322
  • [36] New developments in mild cognitive impairment and Alzheimer's disease
    Schott, Jonathan M.
    Kennedy, Jonathan
    Fox, Nick C.
    CURRENT OPINION IN NEUROLOGY, 2006, 19 (06) : 552 - 558
  • [37] Parkinson's Disease, Diabetes and Cognitive Impairment
    Ashraghi, Mohammad R.
    Pagano, Gennaro
    Polychronis, Sotirios
    Niccolini, Flavia
    Politis, Marios
    RECENT PATENTS ON ENDOCRINE METABOLIC & IMMUNE DRUG DISCOVERY, 2016, 10 (01) : 11 - 21
  • [38] Network substrates of cognitive impairment in Alzheimer's Disease
    Tait, Luke
    Stothar, George
    Coulthard, Elizabeth
    Brown, Jon T.
    Kazanina, Nina
    Goodfellow, Marc
    CLINICAL NEUROPHYSIOLOGY, 2019, 130 (09) : 1581 - 1595
  • [39] Alteration of Gut Microbiota in Alzheimer's Disease and Their Relation to the Cognitive Impairment
    Khedr, Eman M.
    Omeran, Nehad
    Ramadan, Haidi Karam-Allah
    Ahmed, Gellan K.
    Abdelwarith, Ahmed M.
    JOURNAL OF ALZHEIMERS DISEASE, 2022, 88 (03) : 1103 - 1114
  • [40] Neuropsychology of cognitive ageing, minimal cognitive impairment, Alzheimer's disease, and vascular cognitive impairment
    Lindeboom, J
    Weinstein, H
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 490 (1-3) : 83 - 86